Allergic rhinitis, Allergic ocular conjunctivitis, allergic asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients aged from 4 to 70 years male or female; (2) Diagnosed as allergic conjunctivitis, allergic rhinitis, allergic asthma, urticaria or dermitis; (3) Intradermal skin test or sIgE test must be completed before skin prick test; (4) Written informed consent was received.
Exclusion criteria
Exclusion criteria: (1) Subjects were pregnant or lactating women; (2) Subjects had taken antihistamines before the trail or withdrawal time in less than five half-lives; (3) Subjects were taking the systemic corticosteroids medicine; (4) Subjects had skin nick disease; (5) Subjects had negative result in Positive control test (a wheal=5mm) or positive result in negative control test in the skin prick test; (6) Subjects had skin infections,dermatitis,scar or other pathological changes; (7) Subjects had participated in other clinical trial in the recent 3 months; (8) Subjects had systemic diseases, such as hypertension or coronary heart disease (CHD); (9) Subjects were taking beta blockers, including topical treatment; (10) Subjects were in acute exacerbation, such as in the acute exacerbation of allergic asthma; (11) Subjects were Suffering from psoriasis; (12) In other conditions which the investigators considered unsuitable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensibility, specificity, positive predictive values, negtive predictive values;Safety; | — |
Countries
China
Contacts
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences